Bansal Pharma Limited - Due diligence report

A 360° intelligence report on Bansal Pharma Limited: trust score, financial health, credit view, compliance, directors, growth and distress …

1997-09-11 Thane, Maharashtra Active Unlisted Active Compliant
Connect MCP
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Bansal Pharma Limited — 360° Intelligence Report

Generated from MCA filings & public records
76/100
Trust Score
Low Risk

Bansal Pharma Limited is assessed as Low Risk with a Trust Score of 76/100. Bansal Pharma Limited is an active public limited indian non-government company incorporated in 1997, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and moderate financial risk profile.

Report generated on 25 Oct 2026 from the latest processed filings. Bansal Pharma Limited snapshot & full profile →

Financial Health › Good
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
76/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
74/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
60/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
50/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 50/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.

Charges position: 0 open (-) · 4 satisfied (2.78 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Corporation Bank2 48.0 cr
The Saraswat Co-Operative Bank Ltd2 48.0 cr
Compliance Score: 74/100 Moderate
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2025).
  • Litigation present in 2 court forum(s).
  • 1 active GST registration(s).
Legal cases on record (2)
05

Director Intelligence

Stability score: 90/100
NameDIN / PANDesignationAppointedTenureDIN status
SAJANKUMAR RAMESHWARLAL BAJAJ 01234567 Director 01/04/2018 6 yrs Approved
ANIL CHAMPALAL JAIN 01234567 Director 01/04/2018 6 yrs Approved
NAMRATA SAJANKUMAR BAJAJ 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • 2 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 50 · Distress 75
Growth signals & trust indicators
Latest year revenue grew 38%.
Operating for 29+ years.
Active GST registration(s).
Distress signals & risk flags
Losses deepening year-on-year.
2 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence75/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment59/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view60/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2025
Last AGM held
Annual general meeting
29 Sep 2025
Director ceased
NAMRATA SAJANKUMAR BAJAJ
05 Jun 2025
Director ceased
DHANANJAY HATLE SABAJI
01 Apr 2025
Director appointed
NAMRATA SAJANKUMAR BAJAJ (Director)
31 Mar 2025
Latest balance sheet
Filed with ROC
28 Aug 2014
Director ceased
GOPAL VAIKUNTHLAL MEHTA
31 Jan 2008
Director ceased
AJIT AMBALAL SHAH
31 Aug 2007
Charge satisfied
Corporation Bank
20 Jul 2007
Charge satisfied
The Saraswat Co-Operative Bank Ltd
20 Feb 2004
Charge created
The Saraswat Co-Operative Bank Ltd - 75.00 Lakh
04 Nov 1999
Charge created
The Saraswat Co-Operative Bank Ltd - 3.30 Lakh
23 Aug 1999
Charge created
Corporation Bank - 1.00 cr
31 Jul 1999
Director appointed
ANIL CHAMPALAL JAIN (Director)
01 Apr 1998
Director appointed
SAJANKUMAR RAMESHWARLAL BAJAJ (Director)
11 Sep 1997
Incorporated
Registered with Roc Mumbai Ii
10

Key Observations

Auto-generated from the data above
Revenue declined 1.42 over the last 4 financial year(s).
Net profit margin moved from 2.1x to 24%.
Net worth is positive.
3 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
All 4 registered charge(s) stand satisfied - past borrowings repaid.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Snapshot Tracon Pvt Ltd U51109WB1995PTC074417 Kolkata, West Bengal, India
Vanmala Textrade Private Limited U51109WB1995PTC074062 Kolkata, West Bengal, India
Gravity Traders Pvt Ltd U51909WB1995PTC071577 Kolkata, West Bengal, India
Savitri Telecom Services Limited U64200DL2019PLC358896 New Delhi, Delhi, India
Rasons Foods Private Limited U52609MP2021PTC056081 Bhopal, Madhya Pradesh, India
Purav Trading Limited U01119MH1993PLC074630 Mumbai, Maharashtra, India
M. M. Wafer Food Products Private Limited U15500MH2013PTC248688 Mumbai, Maharashtra, India
Medidawa Technologies Private Limited U24304RJ2021PTC077465 Jaipur, Rajasthan, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Bansal Pharma Limited before audits and certifications: compliance score 74/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Bansal Pharma Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 50/100, margin trends, ownership structure and peer set for Bansal Pharma Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 76/100, distress signals and MSME payment-delay disclosures - know whether Bansal Pharma Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Bansal Pharma Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Bansal Pharma Limited an active company?

Bansal Pharma Limited has MCA status “Active” with a compliance score of 74/100 (Moderate).

Is Bansal Pharma Limited financially healthy?

Bansal Pharma Limited has a Financial Health Score of 60/100 (Moderate) based on its filed financial statements.

Should I do business with Bansal Pharma Limited?

Its overall Trust Score is 76/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Bansal Pharma Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Bansal Pharma Limited have loans or charges against its assets?

No open charges - all 4 registered charge(s) stand satisfied, indicating past borrowings were repaid.

Is Bansal Pharma Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2025). Overall compliance score: 74/100 (Moderate).

Is it risky to lend to Bansal Pharma Limited?

Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.